Centiva Capital, LP Pfizer Inc Call Options Transaction History

Centiva Capital, LP

$4.79 Billion
Q3 2024

Call Options

20 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $731,280 - $828,696	-26,400 Reduced 65.02%	14,200 $410,000
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $366,270 - $429,200	-14,500 Reduced 26.32%	40,600 $1.14 Million
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $3.18 Million - $3.66 Million	-123,000 Reduced 69.06%	55,100 $1.53 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $4.12 Million - $5.35 Million	157,600 Added 768.78%	178,100 $5.13 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $657,845 - $768,955	20,500 New	20,500 $679,000
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $1.63 Million - $2.13 Million	-41,500 Reduced 80.27%	10,200 $416,000
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $1.46 Million - $1.91 Million	35,000 Added 209.58%	51,700 $2.65 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $218,800 - $267,100	-5,000 Reduced 23.04%	16,700 $731,000
Q2 2022 Aug 17, 2022	BUY	$46.53 - $55.17 $497,871 - $590,319	10,700 Added 97.27%	21,700 $1.14 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $5.53 Million - $6.85 Million	-120,900 Reduced 91.66%	11,000 $570,000
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $5.15 Million - $7.64 Million	124,720 Added 1737.05%	131,900 $7.79 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $203,315 - $261,175	5,180 Added 259.0%	7,180 $311,000
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $807,974 - $915,300	-22,500 Reduced 91.84%	2,000 $78,000
Q1 2021 May 17, 2021	SELL	$33.49 - $37.77 $10.1 Million - $11.4 Million	-301,600 Reduced 92.49%	24,500 $887,000
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $10.9 Million - $13.9 Million	326,000 Added 326000.0%	326,100 $12 Million
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $2,703 - $3,861	100 New	100 $3,000
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $2.29 Million - $2.51 Million	-61,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $1.64 Million - $1.99 Million	47,600 Added 355.22%	61,000 $2.69 Million
Q2 2018 Aug 03, 2018	SELL	$32.98 - $35.16 $1.49 Million - $1.59 Million	-45,100 Reduced 77.09%	13,400 $487,000
Q1 2018 May 14, 2018	BUY	$31.91 - $37.02 $1.87 Million - $2.17 Million	58,500 New	58,500 $2.08 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

Vanguard Group Inc Valley Forge, PA

516M
Shares

$13.7 Billion
0.27% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.3 Billion
0.27% of portfolio
State Street Corp Boston, MA

290M
Shares

$7.73 Billion
0.35% of portfolio
Wellington Management Group LLP Boston, MA

164M
Shares

$4.36 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.46 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Account